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Edited by Barry HalliwellAbstract The diverse eﬀects of diﬀerent natural and synthetic
oestrogen receptor ligands depend on induction of diﬀerent recep-
tor conformations, allowing diﬀerential interactions with other
transcription factors. Diﬀerent conformations of the oestrogen
receptor ligand binding domains can be monitored by conforma-
tion-speciﬁc binding to peptides selected from phage-displayed
peptide libraries. We now report that a group of chlorinated pes-
ticides, including 2,4-dichlorodiphenyl-dichloroethylene, induces
a peptide recognition pattern diﬀerent from those induced by
any one of the classical oestrogen receptor ligands. The pesti-
cide-complexed oestrogen receptors recognized peptides reacting
with the receptors complexed both with the natural oestrogen
17b-oestradiol and with the synthetic partial antagonist 4-hydro-
xy-tamoxifen, respectively, indicating that the pesticide-induced
conformation shares features with both the 17b-oestradiol- and
the 4-hydroxy-tamoxifen-induced conformations. The substitu-
tion H524A in the ligand binding domain conferred the pesti-
cide-speciﬁc peptide recognition pattern and transactivation
activity to the oestradiol- and the 4-hydroxy-tamoxifen-com-
plexed receptors, indicating that one important determinant of
the pesticide-induced conformation is a lack of stabilisation of
any one particular receptor conformation by ligand interaction
with H524, which is known to interact with both oestradiol and
4-hydroxy-tamoxifen. Thus, peptide binding analyses of oestro-
gen receptor conformations induced by environmental endocrine
disruptors can give novel information about molecular mecha-
nisms of oestrogen action in general.
 2004 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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The physiological eﬀects of oestrogens are mediated by the
oestrogen receptors (ERs), ERa and ERb, members of the nu-
clear receptor family of ligand-regulated transcription factors.
Hormone binding to the ERs ligand-binding domain (LBD)
initiates a series of molecular events culminating in the activa-
tion or repression of target genes [1,2]. When oestradiol (E2),*Corresponding author. Fax: +45 8612 3178.
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doi:10.1016/j.febslet.2004.12.025the natural oestrogen, binds to ERs, the phenolic hydroxyl
of its A-ring nestles between a-helix (H) 3 and H6 of the recep-
tor and makes direct hydrogen bonds to the carboxylate of
Glu353 and the guanidinium group of Arg394 (using the
ERa residue numbering system). The 17b hydroxyl of oestra-
diols D-ring makes a hydrogen bond with His524 in H11.
Transcriptional regulation arises from direct interaction of li-
gand-occupied ERs with its cognate DNA target site (oestro-
gen responsive elements, EREs) in the regulatory regions of
oestrogen-sensitive genes [3–5]. Moreover, conformational
changes of the LBD induced by ligand binding confer further
speciﬁcity upon the hormonal response and is a key event per-
mitting discrimination between agonists (E2, oestriol (E3)),
partial antagonists (4-hydroxytamoxifen (OHT)), and pure
antagonists (ICI 182780). The most prominent conformational
change is a ligand-mediated repositioning of H12. In the ago-
nist-liganded receptor, H12 lies over the ligand-binding cavity
and forms, together with H3 and H5, a binding surface for
transcriptional co-regulators. In receptor liganded by partial
antagonists, H12 occupies the groove between H3 and H5
and prevents co-regulator binding. With pure antagonists,
H12 is pushed away and is invisible in X-ray crystal structure
analysis. Diﬀerent positionings of H12 and associated changes
in other helices thus result in diﬀerent co-regulator binding sur-
faces and hence underlie the diﬀerent physiological eﬀects of
agonists and antagonists [6–9].
In recent decades, there has been an increasing concern
about environmental chemicals that may interfere with oestro-
genic signalling and adversely aﬀect normal reproduction of
humans and wildlife. These compounds, known as environ-
mental endocrine disruptors, encompass a wide range of
substances including natural products, pesticides, pharmaceu-
ticals and industrial chemicals [10–12]. Some of those chemi-
cals have shown either ER agonistic or antagonistic
properties in cell proliferation and transactivation assays with
the breast carcinoma cell line MCF-7 [13]. Many of them, espe-
cially a number of widely distributed pesticides, do not share
any obvious structural similarity to natural oestrogens, making
their identiﬁcation, based solely on molecular structure, impos-
sible [10,14,15].
In the present study, we have investigated oestrogen receptor
conformational changes mediated by 2,4-dichlorodiphenyl-
dichloroethylene (DDE), a metabolite of 2,4-dichlorodiphe-
nyl-trichloroethane (DDT), and other pesticides. For the
study, we have utilized the ability of peptides isolated fromblished by Elsevier B.V. All rights reserved.
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formations [16]. We have found that a group of chlorinated
pesticides induces a ER peptide recognition pattern not de-
scribed before and hence an ER conformational state, which
is not shared with any of the classical ER ligands. Moreover,
we demonstrate by site-directed mutagenesis in phage dis-
played peptide binding and transactivation assays that
His524 is one important determinant for the ligand-induced
conformational changes. Our studies give novel important
information about ER conformational changes and the mech-
anisms by which endocrine disruptors may interfere with oest-
rogen action.2. Materials and methods
2.1. Materials
The following materials were purchased from the indicated suppli-
ers: streptavidin (Calbiochem, San Diego, CA, USA); ERa and ERb
(Panvera, Madison, WI, USA); DNA cassettes, primers, and biotinyl-
ated oligonucleotides corresponding to vitellogenin ERE (biotin-GAT-
CTAGGTCACAGTGACCTGCG – forward and biotin-GATCCGC
AGGTCACTGTGACCTA – reverse) (DNA Technology, Aarhus,
Denmark); E2, E3, and OHT (Sigma, St. Louis, MO, USA); DDE
and other pesticides (Dr. Ehrenstorfer, Augsburg, Germany); mouse
anti-M13 monoclonal antibody conjugated with horseradish peroxi-
dase (HRP) and anti-glutathione-S-transferase (GST) goat antibody
(Amersham Biosciences, Hillerød, Denmark); glutathione-(GSH) aga-
rose (Molecular Probes, Eugene, OR, USA); biotinylated GSH (Bio-
peptide, San-Diego, CA, USA); MaxisorpTM microtitre plates
(Nunc, Roskilde, Denmark); E. coli BL21 (Stratagene, La Jolla, CA,
USA); and FuGene6 (Roche Diagnostics Corp., Indianapolis,
IN, USA). All other chemicals were of the best grade commercially
available.
2.2. Fusion phage
M13 phage particles displaying ER-binding peptides were prepared
by ligating oligonucleotide cassettes coding for each peptide into SﬁI-
digested fUSE5 vector followed by production of fusion phage in E.
coli DH-5a cells [17]. The created fusion phage was validated by
DNA sequencing of PCR products generated with the primers
M13for (5 0-TTTCGACACAATTTATCAGG-3 0) and M13back (5 0-
TGAATTTTCTGTATGAGGTTTTG-3 0) and Taq DNA polymerase
(Invitrogen, Denmark). The PCR-products were puriﬁed (Qiaquick
PCR Puriﬁcation Kit, Qiagen, Germany) and sequenced with the
DYEnamic ET Terminator Cycle Sequencing Kit (Amersham Biosci-
ences, Hillerød, Denmark) and an ABI PRISM 3100 Genetic Analyzer
(Applied Biosystems, CA, USA).
2.3. Site-directed mutagenesis and puriﬁcation of the GST-ERa-LBD
fusion protein
The H524A mutation was introduced into the GST-ERa-LBD
expression vector, kindly provided by Dr. M. Brown (Boston, MA,
USA) [18], using the QuickChange Site-Directed Mutagenesis Kit
(Stratagene, La Jolla, CA, USA) with the primers 5 0-GGCATG-
GAGGCGCTGTACAGCATGAAGTGCAAGAACGTGGTGCCC-
3 0 and 5 0-GGGCACCACGTTCTTGCACTTCATGCTGTACAGCG
CCTCCATGCC-3 0. The ERa-LBD-H524A coding region and its
ﬂanking cloning sites were validated by DNA sequencing as described
above. GST-ERa-LBD and GST-ERa-LBD-H524A fusion proteins
were puriﬁed from E. coli BL21 cells harbouring the corresponding
expression vectors. Brieﬂy, gene expression was induced by adding 1
mM isopropyl-b-D-thiogalactopyranoside (IPTG) to log-phase cul-
tures followed by incubation for 2 h at 37 C. Cells were harvested
by centrifugation and lysed by sonication on ice in a buﬀer containing
20 mM Tris–HCl (pH 8.0), 100 mM NaCl, 10 lM ZnCl2, 0.5% NP-40,
0.5 mM dithiothreitol, 1 mM phenyl-methyl-sulfonyl-ﬂuoride and 0.3
lg/ml lysozyme. Cell debris was removed by centrifugation and the
GST-ERa-LBD fusion proteins were puriﬁed by chromatography on
a GSH-agarose column as described [10].2.4. Phage ELISA with full-length ERs and with GST-ERa-LBD
The ELISAs were performed at 37 C in TBST buﬀer (10 mM Tris–
HCl, pH 8.0, 150 mM NaCl, and 0.05% Tween 20) [16,19]. Two ELI-
SA formats were used. In ELISA-format I, wells of a microtitre plate
coated with streptavidin [19] were incubated with biotinylated vitello-
genin ERE (2 pmol per well) for 1 h followed by monomeric, full-
length ERa or ERb (2 pmol per well) for 1 h. In ELISA-format II,
the streptavidin-coated wells [20] were incubated with biotinylated
GSH (100 pmol per well) for 1 h followed by GST-ERa-LBD (3 pmol
per well) for 1 h. In both ELISA formats, fusion phage (1010 colony
forming units per well) was allowed to bind to the immobilized ER or
GST-ERa-LBD, respectively, in the presence of the appropriate ER li-
gand as indicated for each experiment. After extensive washing, the
bound fusion phage was detected with a HRP-conjugated anti-M13
monoclonal antibody and a peroxidase reaction (ortho-phenylenedi-
amine/H2O2, Kem-En-Tek Diagnostics, Copenhagen, Denmark). The
reactions were quenched after 10 min with an equal volume of 1 M
H2SO4 and the colour development was measured in a microplate
reader as the absorbance at 492 nm.
The ligand concentrations giving a half-maximal response in the
phage ELISAs, i.e., the EC50 values, were calculated by plotting the
relative signals semilogarithmically versus the ligand concentrations
and ﬁtting a curve to the data on the basis of the equation: Relative
signal = EC50/([ligand] + EC50), using SigmaPlot.
2.5. Cell culture and transient transfections
Chinese hamster ovary cells (CHO-K1) were grown in the
DMEM/F12 supplemented with 10% heat inactivated foetal calf ser-
um, 2 mM L-glutamine, and 0.64 lg/ml garamycine in a humidiﬁed
5% CO2 atmosphere at 37 C. 7 · 103 cells were seeded in each well
of 96 well plates 1 day before co-transfection with the plasmids
encoding wild type full-length human ERa (generously provided by
S. Green and P. Chambon, Strasbourg, France) or a mutated ver-
sion of the same plasmid, in which His524 was substituted to Ala
(H524A), together with the reporter plasmid pERE-sv luc, based
on the pGL3-promoter vector (Promega) carrying the Xenopus laevis
vitellogenin ERE upstream of the SV40 promotor and the coding
region of the ﬁreﬂy luciferase gene [13] in a ratio of 1:10000. Co-
transfection was performed by a total of 150 ng of DNA during
5 h using FuGene6 reagent according to the manufacturers proto-
col. The cells were harvested after 19 h and the luciferase activity
analysed as described [13]. The measured luciferase activities were
corrected for variations in cell density by normalisation against the
protein content of each sample, determined by adding 50 lL ﬂuores-
camine (0.5 g/L) diluted in acetonitrile to each well and ﬂuorometric
measurements in the WALLAC VICTOR2 (PerkinElmer, USA) at
355/460 nm [21].
2.6. Statistical analysis
Each experiment was performed three independent times (4–6 wells
for each transfection). Unless otherwise indicated, statistical analysis
was done using the two-tailed Students t test with a signiﬁcance level
of P < 0.01.3. Results
A number of peptides, each with a speciﬁc pattern of recog-
nition of diﬀerent ER conformations, were previously isolated
by Paige et al. [16] from a phage displayed peptide library.
Among those, we chose 5 peptides, which allow the speciﬁc
recognition of ERa and ERb conformations induced by E2,
E3, OHT and ICI182780, respectively. To investigate the inter-
actions of peptides, which we considered optimal – a/bI
(SSNHQSSRLIELLSR), a/bII (SAPRATISHYLMGG),
a/bIII (SSWDMHQFFWEGVSR), aII (SSLTSRDFGSW-
YASR), and bII (SSLDLSQFPMTASFLRESR) – we used
an ELISA with streptavidin coated onto the solid phase, fol-
lowed by a layer of biotinylated vitellogenin ERE; a layer of
full-length human ERa or ERb in combination with 1 lM of
various ligands; a layer of fusion phage displaying one of the
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body. a/bII recognized non-liganded receptors, a/bI recog-
nized E2- and E3-complexed ERa, bII recognized E2- and
E3-liganded ERb, a/bIII recognized OHT-complexed recep-
tors, and aII recognized ERa complexed with any ligand.
ICI 182780 suppressed the a/bII binding but E3 did not do
so completely (Fig. 1). These peptide recognition patterns were
consistent with the data reported previously [16,19]. We were
thus able to reproduce the original ﬁnding [16] that diﬀerent
conformations induced by diﬀerent ligands can be distin-
guished by their peptide recognition patterns.
We then screened DDE and 24 other widely distributed pes-
ticides with the same approach to examine whether they induce
ER conformational changes. ERa incubated with DDE, endo-
sulfan, dieldrin, vinclozolin, iprodione and paclobutrazol
bound a/bI, a/bIII and aII. ERb incubated with these com-Fig. 1. Peptide recognition pattern of ERa and ERb complexed with establis
presence of 1 lM of the indicated ligands was estimated by ELISA format I w
immobilized on the solid phase. The signals obtained with peptides a/bI and
with other peptide/ligand combinations expressed as a fraction thereof. Datapounds bound bII and a/bIII. The pesticide-complexed ERs
had a lower aﬃnity to the peptides than the ERs complexed
with the other ligands (Figs. 1 and 2). This peptide recognition
pattern diﬀers from the patterns induced by any other tested
ligand. We will refer to the peptide recognition pattern induced
by the chlorinated pesticides as the DDE-type peptide recogni-
tion pattern. Fenarimol was found to give the same peptide
recognition pattern as OHT. Prochloraz was found to give
the same pattern as ICI 182780 (Fig. 2). Testing the sensitivity
of the assay to diﬀerent concentrations of the ligands, we
found that the response increased with the ligand concentra-
tion, to reach saturation below 1 lM in all cases. A represen-
tative experiment, with DDE, is shown in Fig. 3. This
conclusion is also evident from the lack of binding of the a/
bII peptide with the 1 lM pesticide concentration used rou-
tinely (Figs. 1 and 2). Thus, the variation described abovehed ligands. The binding of indicated peptides to ERa and ERb in the
ith the peptides displayed on M13 phage and full-length ERa and ERb
ERa in the presence of E2 were set to 100%, and the signals obtained
are shown as means ± S.D. of at least ﬁve individual experiments.
Fig. 2. Peptide recognition patterns of ERa and ERb complexed with
chlorinated pesticides. For details, see legend to Fig. 1.
Fig. 3. Interactions between ERa-LBD and conformation-speciﬁc
peptides in the presence of various concentrations of DDE. The ERa-
LBD was incubated with 1–10000 nM DDE. Binding of the
conformation speciﬁc peptides was detected. The signals obtained
were expressed relative to the signal obtained with the peptide a/bI and
ERa LBD in the presence of E2. Data are shown as means ± S.D. of
three individual experiments.
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tial aﬃnity of the saturated receptors to the peptides. The EC50
value for each compound tested was estimated as the concen-tration of the compound halving the signal obtained with the
a/bII peptide speciﬁcally recognising the non-liganded receptor
(Table 1).
Seventeen other pesticides (pirimicarb, propamocarb, fenp-
ropathrin, deltamethrin, chlorpyrifos, methiocarb, methiocarb
sulfoxide, dimethoate, dichlorvos, tolchlofos-methyl, meth-
omyl, chlorothalonil, phosetyl-aluminium, tribenuron methyl,
diaminozide, chlormequat and ethephon) were found not to
lead to any changes compared to the non liganded ERs in
the peptide recognition pattern when tested in a concentration
of 1 lM (data not shown).
Taken together, our data suggest that DDE and several
other pesticides induce a previously unrecognized ER confor-
mational state. Considering the molecular structures of these
ligands, we hypothesized that they interact directly with the
part of the ligand binding cavity which binds the A-ring of
E2. However, we would expect them to be unable to interact
with His524, which interacts with the D-ring of E2, and this
Table 1
The EC50 values for induction of conformational changes of ERa by
various ligands
Compound EC50 (nM)
E2 3.7 ± 0.4
OHT 2.8 ± 0.3
ICI 182780 9.0 ± 2
DDE 16 ± 4
Endosulfan 85 ± 30
Dieldrin 21 ± 6
Vinclozolin 11 ± 4
Iprodione 13 ± 5
Paclobutrazol 12 ± 4
Fenarimol 30 ± 14
Prochloraz 84 ± 32
The EC50 values were determined as the ligand concentrations halving
the signal obtained with a/bII, the peptide recognising speciﬁcally the
unliganded ERa. The assay was run in the ELISA set-up with ERa-
LBD fused to GST. Means and S.D. for three determinations are
indicated.
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hence the diﬀerent peptide recognition pattern. To test our
hypothesis, we substituted His524 to Ala by site-directed muta-
genesis. According to the literature, this mutation decreases
the aﬃnity of both E2 and OHT to the receptor [22,23]. In or-
der to simplify the protein puriﬁcation and to verify that the
peptides recognized exactly the LBD, we used the human
ERa-LBD fused to the C-terminus of GST. The construct
was immobilized on biotinylated GSH bound to streptavidin
coated onto the solid phase of microtitre plates, followed by
incubation with 1 lM of various ligands in the presence of fu-
sion phage displaying a/bI, a/bII, a/bIII, or aII. The peptide
recognition patterns of GST-ERa-LBD wild type (wt) were
identical to those of the full-length ERa (Fig. 4). However,
in contrast to the wt, E2-, OHT-, and fenarimol-liganded
GST-ERa-LBD, the H524A was recognized by a/bI, a/bIII
and aII (Fig. 4), although the interactions were weaker than
in the case of wt. Thus, with the mutant, all these compounds
gave the DDE-type peptide recognition pattern. No changes in
peptide recognition pattern and aﬃnity were observed for
DDE, endosulfan, dieldrin, vinclozolin, iprodion and pac-
lobutrazol. Also, the peptide recognition patterns given by
ICI 182780 and prochloraz were not changed by the substitu-
tion although the peptide aﬃnity was reduced (Fig. 4). Thus, it
seems that the H524A mutation equalizes agonists, partial
antagonists and chlorinated pesticides to all give the DDE-type
peptide recognition pattern, while the pure antagonists main-
tain theirs. This conclusion is in agreement with the hypothesis
that the lack of interaction of the respective chlorinated pesti-
cides with His524 is critical for the DDE-type peptide recogni-
tion pattern.
To support our ﬁnding with the peptides, we investigated the
ability of the various pesticides to induce transactivation of
vitellogenin ERE by ERa wild type and ERa H524A. CHO-
K1 cells were co-transfected with wild type or H524A full-
length ERa-encoding plasmids together with a plasmid with
the ﬁreﬂy luciferase gene under transcriptional control of the
vitellogenin ERE. Cells were incubated in the presence of 0,
10, 100 and 1000 nM E2, OHT, DDE and fenarimol followed
by the luminometric detection of the luciferase activity. E2 and
DDE, but not OHT or fenarimol, activated wild type ERa-
dependent transcription from the vitellogenin ERE (Fig. 5).
Substitution of His524 to Ala decreased the E2, but not theDDE-mediated transactivation. Also, OHT and, with less
aﬃnity, fenarimol were found to induce ERaH524A transcrip-
tional activity in DDE-like manner (Fig. 5).4. Discussion
The peptide recognition pattern of ERa and ERb in complex
with DDE and the other chlorinated pesticides is the sum of the
peptide recognition patterns of ERa and ERb in complex with
E2 and OHT, respectively, although the pesticide-complexed
receptors gave a weaker interaction with a/bI, a/bIII and aII
than the E2- and OHT-complexed receptors. On the other
hand, the pesticide-induced peptide recognition pattern was
clearly diﬀerent from the patterns induced by ICI 182780 and
E3 and the patterns of the unliganded receptors. We therefore
propose that the DDE-type peptide recognition pattern reﬂects
a conformation, which possesses features of both the E2- and
the OHT-induced conformations. It was recently proposed that
the ER LBD is in a state of ‘‘ligand-sensitive conformational
equilibrium’’ between diﬀerent conformations [9]. Applying
this concept on our present data would imply that pesticide-
complexed ERs are in equilibrium between states resembling
the more stable conformations induced by E2 and OHT,
respectively. Since a/bI binds in the co-regulator-binding
groove [16], which is occupied by H12 in the OHT-complexed
receptors [6,7], one aspect of the conformational equilibrium
could be H12 switching between the position over the ligand-
binding pocket and the co-regulator binding groove position.
However, as the binding site for a/bIII is unknown, smaller
changes in the other helices may be equally important. The
strategy of deﬁning ER conformations by their peptide recogni-
tion pattern was also recently utilized by Iannone et al. [24]. In
contrast to the static picture provided by a crystal structure,
this analysis may provide a sense of the dynamic state of the
receptor in balance between conformations with diﬀerent func-
tional properties. For example, the three-dimensional struc-
tures of ERa in complex with E2 or the phyto-oestrogen
genistein, determined by X-ray crystal structure analysis, are
very similar [7], but E2- and genestein-complexed ERa gave dif-
ferent peptide recognition patterns in our ELISA assays, where
genistein reacted like E3 (data not shown).
We showed that an H524A mutation in ERa LBD caused
the ERa-E2 complex and the ERa-OHT complex to assume
the DDE-type peptide recognition pattern. According to the
above proposal of a ligand-sensitive conformational equilib-
rium, this observation has to be interpreted as His524 being
important for the stability of E2- and OHT- induced confor-
mations. Previous evidence has suggested that improper con-
tacts of the D-ring of E2 and similar ligands may induce an
antagonistic conformation, including positioning of H12 over
the co-regulator groove [9,25]. The H524A mutation did not
cause the ERa-ICI 182780 complex to assume the same pep-
tide recognition pattern, in agreement with the long side chain
of ICI 182780 severely restricting the conformational ﬂexibil-
ity. Interestingly, the H524A mutation did also not change
the ICI-like ERa-prochloraz peptide recognition pattern, in
accordance with the observed ERa antagonistic capacity of
prochloraz cell-based assays [13,26,27].
In order to support our data with peptide binding, we per-
formed co-transfection experiments with ERa wt or ERa
H524A and a reporter gene under the control of a X. laevis
Fig. 4. Peptide recognition patterns of ERa-LBD wt and ERa-LBD-H524A complexed with established ligands and chlorinated pesticides. The
binding of the indicated peptides to GST-ERa-LBD wild type (h) and GST-ERa-LBD-H524A (j) in the presence of 1 lM of the indicated ligands
was estimated by ELISA format II with peptides displayed on M13 phage or GST-ERa-LBD immobilized on the solid phase via biotinylated GSH
and streptavidin. The signal obtained with the a/bI peptide, E2, and GST-ERa-LBD wt was set to 100%, and the signals obtained with other peptide/
ligand/GST-ERa-LBD variant combinations expressed as a fraction thereof. Data are shown as means ± S.D. of at least ﬁve individual experiments.
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varied in parallel with the aﬃnity of the receptor to a/bI, in
good agreement with the observation that oestrogen stimula-
tion of transcription from the X. laevis vitellogenin ERE in
CHO-K1 cells depends on interaction with the steroid receptor
co-activator protein-1 (SRC-1) [28], having the same ERabinding motif (LXXLL) as a/bI. The co-transfection data thus
conﬁrm our in vitro peptide binding data. Due to the proposed
intrinsic properties of the pesticide-complexed ERs, being in
an equilibrium between agonistic and antagonistic conforma-
tions, the exact state of the equilibrium varying slightly
between individual pesticides and depending on the complexes
Fig. 5. Wild type and H524A ERa transactivation upon stimulation
with diﬀerent ligands. CHO-K1 cells were co-transfected with wild type
or H524A full-length ERa encoding plasmid together with the pERE-
sv luc luciferase encoding reporter plasmids. Cells were stimulated with
10, 100 and 1000 nM E2, OHT, DDE and fenarimol, followed by the
luminometric detection of the luciferase activity. All combinations of
ligands and concentrations were examined with 4–6 dations in each
one of 3–4 independent experiments. A Bartletts test showed that the
variances and the means did not vary signiﬁcantly from one experi-
ment to the next. Data are therefore shown as means ± S.D. of all
determinations. \: indicates that the data are signiﬁcantly diﬀerent
(P < 0.01) from the respective control values (0 wt or 0 H524A); \\:
indicates that the data obtained by the H524A plasmid are signiﬁcantly
diﬀerent (P < 0.01) from the corresponding data obtained by wt ER
plasmid, as well as from the respective control values.
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with cellular co-regulators, we would expect the transcriptional
response to be diﬀerent in other cell types with other comple-
ments with co-regulators. In fact, another transactivation as-
say with site-speciﬁcally mutated ERa suggested diﬀerent
molecular mechanisms of the oestrogenic eﬀects of E2 and
some non-planar compounds related to DDE [29].
The agonistic and antagonistic eﬀects of the pesticides tested
here were previously studied by cell-based assays, including
transactivation assays with the X. laevis vitellogenin ERE
and MCF-7 proliferation assays [13]. However, those data
are not directly comparable to the present ones, as a diﬀerent
cell line was used, which had an endogenous expression of ERs
and probably a diﬀerent set of co-factors exist and as higher
pesticide concentrations were used in the previous study than
in our study. In general, the interpretation of data obtained
by in vitro and cell-based assays is complicated by several fac-
tors, including restricted penetration of the compounds into
the cells; the compounds being activated or inactivated by cel-
lular metabolism; binding to serum proteins present in the cul-
tures. The combination of animal and cell culture-based assays
with the presently described conformational mapping may re-
solve many of the ambiguities associated with observations
with the more complex biological systems.
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